Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Accentis S.A. | D1Z | 2. avr 2025 | 0.02 | -8.00 |
Accentro Real Estate AG | A4Y | 2. avr 2025 | 0.07 | +31.86 |
Accenture plc Class A Ordinary Shares (Ireland) | CSA | 2. avr 2025 | 290.65 | +0.99 |
Accesso Technology Group Plc | LQG | 2. avr 2025 | 5.05 | 0.00 |
Acciona SA | AJ3 | 2. avr 2025 | 120.10 | -0.17 |
Acco Brands Corporation | A3B | 2. avr 2025 | 3.88 | +1.57 |
Acconeer | 2LU | 2. avr 2025 | 0.47 | -2.20 |
Accor | ACR1 | 2. avr 2025 | 8.35 | +0.60 |
Accor SA | ACR | 2. avr 2025 | 41.98 | -0.02 |
Accsys Technologies | 1D8 | 2. avr 2025 | 0.52 | +0.39 |
Accuray Incorporated | XEJ | 2. avr 2025 | 1.62 | -0.61 |
Ace Hardware Indonesia TBK | 4AH1 | 2. avr 2025 | 0.03 | 0.00 |
ACE LIBERTY+STONE LS -,25 | 8MW | 2. avr 2025 | 0.50 | -2.35 |
ACEA SpA | DCA | 2. avr 2025 | 19.05 | +0.21 |
AcelRx Pharmaceuticals | R5XA | 2. avr 2025 | 0.50 | +12.63 |
Acer Incorporated | AC5G | 2. avr 2025 | 3.94 | +1.03 |
ACERINOX ADR 1/2/EO-,25 | ACE | 2. avr 2025 | 5.35 | +2.88 |
Acerinox SA | ACE1 | 2. avr 2025 | 10.89 | -0.82 |
Achieve Life Sciences, Inc. - | SP4P | 2. avr 2025 | 2.28 | -6.37 |
Achilles Therapeutics plc - American Depositary Shares | 698 | 2. avr 2025 | 1.33 | 0.00 |
ACI Worldwide, Inc. | TSA | 2. avr 2025 | 52.00 | +2.97 |
ACINQUE S.P.A. EO 1 | YA2 | 2. avr 2025 | 2.05 | -0.49 |
Ackermans & van Haaren NV | B3K | 2. avr 2025 | 201.00 | +0.40 |
Aclara Resources Inc | JD1 | 2. avr 2025 | 0.32 | +10.34 |
Aclaris Therapeutics, Inc. | 8AT | 2. avr 2025 | 1.36 | -2.83 |
ACM Research, Inc. - Class A | 813 | 2. avr 2025 | 21.84 | -0.27 |
Acma Ltd | AAX1 | 2. avr 2025 | 0.02 | +6.90 |
Acme United Corporation. | UT1 | 2. avr 2025 | 36.40 | +1.11 |
Acom Co Ltd | AK5 | 2. avr 2025 | 2.30 | -0.86 |
aconnic AG | CFC | 2. avr 2025 | 0.99 | 0.00 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.